212 related articles for article (PubMed ID: 11949943)
1. Paracrine mediators of endometrial matrix metalloproteinase expression: potential targets for progestin-based treatment of endometriosis.
Osteen KG; Bruner-Tran KL; Ong D; Eisenberg E
Ann N Y Acad Sci; 2002 Mar; 955():139-46; discussion 157-8, 396-406. PubMed ID: 11949943
[TBL] [Abstract][Full Text] [Related]
2. Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium.
Osteen KG; Keller NR; Feltus FA; Melner MH
Gynecol Obstet Invest; 1999; 48 Suppl 1():2-13. PubMed ID: 10559659
[TBL] [Abstract][Full Text] [Related]
3. Progesterone-mediated endometrial maturation limits matrix metalloproteinase (MMP) expression in an inflammatory-like environment: a regulatory system altered in endometriosis.
Osteen KG; Bruner-Tran KL; Keller NR; Eisenberg E
Ann N Y Acad Sci; 2002 Mar; 955():37-47; discussion 86-8, 396-406. PubMed ID: 11949963
[TBL] [Abstract][Full Text] [Related]
4. Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice.
Bruner-Tran KL; Eisenberg E; Yeaman GR; Anderson TA; McBean J; Osteen KG
J Clin Endocrinol Metab; 2002 Oct; 87(10):4782-91. PubMed ID: 12364474
[TBL] [Abstract][Full Text] [Related]
5. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
Braundmeier AG; Nowak RA
Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
[TBL] [Abstract][Full Text] [Related]
6. Paracrine regulation of matrix metalloproteinase expression in endometriosis.
Sharpe-Timms KL; Cox KE
Ann N Y Acad Sci; 2002 Mar; 955():147-56; discussion 157-8, 396-406. PubMed ID: 11949944
[TBL] [Abstract][Full Text] [Related]
7. Progesterone and transforming growth factor-beta coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis.
Bruner KL; Eisenberg E; Gorstein F; Osteen KG
Steroids; 1999 Sep; 64(9):648-53. PubMed ID: 10503723
[TBL] [Abstract][Full Text] [Related]
8. Progesterone action in the human endometrium: induction of a unique tissue environment which limits matrix metalloproteinase (MMP) expression.
Osteen KG; Igarashi TM; Bruner-Tran KL
Front Biosci; 2003 Jan; 8():d78-86. PubMed ID: 12456342
[TBL] [Abstract][Full Text] [Related]
9. [Matrix metalloproteinases and their role in menstruation and endometriosis].
Hudelist G; Singer CF; Keckstein J
Zentralbl Gynakol; 2005 Oct; 127(5):320-4. PubMed ID: 16195977
[TBL] [Abstract][Full Text] [Related]
10. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration.
Gaide Chevronnay HP; Selvais C; Emonard H; Galant C; Marbaix E; Henriet P
Biochim Biophys Acta; 2012 Jan; 1824(1):146-56. PubMed ID: 21982799
[TBL] [Abstract][Full Text] [Related]
11. Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis.
Osteen KG; Bruner-Tran KL; Eisenberg E
Fertil Steril; 2005 Mar; 83(3):529-37. PubMed ID: 15749474
[TBL] [Abstract][Full Text] [Related]
12. The role of matrix metalloproteinases in the pathogenesis of endometriosis.
Pitsos M; Kanakas N
Reprod Sci; 2009 Aug; 16(8):717-26. PubMed ID: 19351962
[TBL] [Abstract][Full Text] [Related]
13. Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2.
Uzan C; Cortez A; Dufournet C; Fauvet R; Siffroi JP; Daraï E
Virchows Arch; 2004 Dec; 445(6):603-9. PubMed ID: 15452706
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of endometrial matrix metalloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget.
Bruner-Tran KL; Zhang Z; Eisenberg E; Winneker RC; Osteen KG
J Clin Endocrinol Metab; 2006 Apr; 91(4):1554-60. PubMed ID: 16418212
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and endometriosis.
Osteen KG; Yeaman GR; Bruner-Tran KL
Semin Reprod Med; 2003 May; 21(2):155-64. PubMed ID: 12917785
[TBL] [Abstract][Full Text] [Related]
16. Premenstrual and menstrual changes in the macaque and human endometrium: relevance to endometriosis.
Brenner RM; Nayak NR; Slayden OD; Critchley HO; Kelly RW
Ann N Y Acad Sci; 2002 Mar; 955():60-74; discussion 86-8, 396-406. PubMed ID: 11949966
[TBL] [Abstract][Full Text] [Related]
17. Circulating ovarian steroids and endometrial matrix metalloproteinases (MMPs).
Henriet P; Cornet PB; Lemoine P; Galant C; Singer CF; Courtoy PJ; Eeckhout Y; Marbaix E
Ann N Y Acad Sci; 2002 Mar; 955():119-38; discussion 157-8, 396-406. PubMed ID: 11949942
[TBL] [Abstract][Full Text] [Related]
18. The relevancy of the matrix metalloproteinase system to the pathophysiology of endometriosis.
Zhou HE; Nothnick WB
Front Biosci; 2005 Jan; 10():569-75. PubMed ID: 15574393
[TBL] [Abstract][Full Text] [Related]
19. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice.
Bruner KL; Matrisian LM; Rodgers WH; Gorstein F; Osteen KG
J Clin Invest; 1997 Jun; 99(12):2851-7. PubMed ID: 9185507
[TBL] [Abstract][Full Text] [Related]
20. Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis.
Grandi G; Mueller MD; Papadia A; Kocbek V; Bersinger NA; Petraglia F; Cagnacci A; McKinnon B
J Reprod Immunol; 2016 Sep; 117():30-8. PubMed ID: 27371899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
